Relative Strength Chart Vertex Pharmaceuticals Incorporated
Stocks
VRTX
US92532F1003
Pharmaceuticals
|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 552.06 USD | +4.52% |
|
+5.01% | +21.77% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Other Pharmaceuticals | +4.52% | +5.01% | +21.77% | +41.28% | +183.05% | 140B |  | | |
- Stock Market
- Stocks
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
